Drug Database
Back to search

Ireland· IE-PA-PA22612/010/011

RISPERDAL CONSTA 37.5 mg powder and solvent for prolonged-release suspension for injection

A risperidone product containing risperidone, registered in Ireland by Janssen Sciences Ireland Unlimited Company. The same ATC class is registered in 19 of our 19 countries.

ATC N05AX08

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedRISPERDAL CONSTA 37.5 mg powder and s…ATCN05AX08REGISTER NO.IE-PA-PA22612/010/011PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about risperidoneAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Risperidone is registered in 19 of 19 countries.

Countries holding a registration under ATC N05AX08 (risperidone), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 11 of them publish a price we can compare per daily dose
Search risperidone products by name

Risperidone · ATC N05AX08

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of risperidone costs, country by country.

Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.52 in Czechia to $3.93 in Switzerland — a ×7.5 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Risperidone · price per daily dose (5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$3.93
  • IT Italy$1.34
  • FR France$0.77
  • CZ Czechia$0.52
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)
Active substance
Risperidone
Manufacturer
Janssen Sciences Ireland Unlimited Company
Country
Ireland (IE)
ATC code
N05AX08
ATC class
Risperidone
Defined daily dose
5 mg, O
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA22612/010/011

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

542 interactions on record for risperidone.

Graded by severity as the source publishes them — 45 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check risperidone against other medicinesHow interaction checks work

Risperidone · interactions on record

542 records

  • 45 severe
  • 286 moderate
  • 4 minor
  • 136 info

Most severe, free to view

  • MetoclopramideA03FA01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • PasireotideH01CB05severe

71 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under N05AX08

Risperidone, as other registers publish it.

All risperidone products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/45187128-602e-4899-b7a4-df5bee86e027
GET /v1/drugs/45187128-602e-4899-b7a4-df5bee86e027?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder and solvent for prolonged-release suspension for injection",
  "routes": [
    "Intramuscular use"
  ],
  "source": "hpra",
  "atc_all": [
    "N05AX",
    "N05AX08"
  ],
  "strength": null,
  "pa_number": "PA22612/010/011",
  "substances": [
    "Risperidone"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "17/12/2002",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": "IC0012-063-065"
}
API referenceMCP serverPlans

See everything about risperidone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console